GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Pre-Tax Income

Actelion (Actelion) Pre-Tax Income : $811 Mil (TTM As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Actelion's pretax income for the three months ended in Mar. 2017 was $215 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2017 was $811 Mil. Actelion's pretax margin was 33.34%.


Actelion Pre-Tax Income Historical Data

The historical data trend for Actelion's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Pre-Tax Income Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 389.10 481.07 550.34 638.61 777.35

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 211.10 214.47 255.77 126.03 215.14

Competitive Comparison of Actelion's Pre-Tax Income

For the Biotechnology subindustry, Actelion's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actelion's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Actelion's Pre-Tax Income falls into.



Actelion Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Actelion's Pretax Income for the fiscal year that ended in Dec. 2016 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=773.702+0+0+0+3.651
=777

Actelion's Pretax Income for the quarter that ended in Mar. 2017 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=214.125+0+0+0+1.015
=215

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $811 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion  (OTCPK:ALIOF) Pre-Tax Income Explanation

Actelion's Pretax Margin for the quarter that ended in Mar. 2017 is calculated as

Pretax Margin=Pretax Income/Revenue
=215.14/645.285
=33.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Actelion's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (Actelion) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Actelion Still On Growth Track

By reports.droy reports.droy 02-18-2015

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 01-24-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 02-14-2017